SurgePays (SURG) Competitors $2.70 -0.05 (-1.82%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.70 +0.00 (+0.19%) As of 08/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. SMTI, SKIN, BWAY, CVRX, MGRM, PTHL, CV, INGN, SGHT, and TLSIShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Sanara MedTech (SMTI), Beauty Health (SKIN), Brainsway (BWAY), CVRx (CVRX), Monogram Orthopaedics (MGRM), Pheton (PTHL), CapsoVision (CV), Inogen (INGN), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. SurgePays vs. Its Competitors Sanara MedTech Beauty Health Brainsway CVRx Monogram Orthopaedics Pheton CapsoVision Inogen Sight Sciences TriSalus Life Sciences Sanara MedTech (NASDAQ:SMTI) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Does the media refer more to SMTI or SURG? In the previous week, SurgePays had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 2 mentions for SurgePays and 0 mentions for Sanara MedTech. SurgePays' average media sentiment score of 0.58 beat Sanara MedTech's score of 0.00 indicating that SurgePays is being referred to more favorably in the news media. Company Overall Sentiment Sanara MedTech Neutral SurgePays Positive Do analysts recommend SMTI or SURG? Sanara MedTech currently has a consensus target price of $49.50, indicating a potential upside of 104.88%. SurgePays has a consensus target price of $9.00, indicating a potential upside of 233.33%. Given SurgePays' higher probable upside, analysts clearly believe SurgePays is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, SMTI or SURG? Sanara MedTech has higher revenue and earnings than SurgePays. Sanara MedTech is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M2.48-$9.66M-$1.34-18.03SurgePays$40.03M1.38-$45.73M-$2.79-0.97 Do insiders and institutionals believe in SMTI or SURG? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 42.6% of Sanara MedTech shares are owned by insiders. Comparatively, 30.5% of SurgePays shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is SMTI or SURG more profitable? Sanara MedTech has a net margin of -12.48% compared to SurgePays' net margin of -136.37%. Sanara MedTech's return on equity of -29.22% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-12.48% -29.22% -13.20% SurgePays -136.37%-206.01%-153.67% Which has more volatility and risk, SMTI or SURG? Sanara MedTech has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. SummarySanara MedTech beats SurgePays on 11 of the 15 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$56.13M$19.21B$29.22B$9.53BDividend YieldN/A2.95%3.09%4.08%P/E Ratio-0.9785.9248.0923.80Price / Sales1.3865.381,529.7188.12Price / CashN/A92.4138.0757.96Price / Book3.558.087.415.55Net Income-$45.73M$341.62M$782.10M$259.03M7 Day Performance-8.16%-6.55%-3.62%-4.56%1 Month Performance-14.56%0.45%-0.08%4.49%1 Year Performance2.66%56.29%52,642.37%18.05% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays3.3398 of 5 stars$2.70-1.8%$9.00+233.3%-0.7%$56.13M$40.03M-0.9740SMTISanara MedTech1.5811 of 5 stars$25.03-2.0%$49.50+97.8%-19.4%$226.91M$86.67M-18.6860SKINBeauty Health1.5018 of 5 stars$1.76-1.7%$1.13-36.1%-10.0%$225.53M$334.30M-4.291,030Trending NewsUpcoming EarningsAnalyst ForecastBWAYBrainsway3.241 of 5 stars$12.00+2.3%$14.25+18.8%+64.6%$221.67M$41.02M60.00120News CoveragePositive NewsUpcoming EarningsGap UpCVRXCVRx2.6904 of 5 stars$8.43+1.1%$14.50+72.0%-8.9%$217.45M$51.29M-3.87160Upcoming EarningsMGRMMonogram Orthopaedics1.2986 of 5 stars$5.69+0.2%$5.40-5.1%+128.4%$202.71M$370K-12.6428News CoveragePositive NewsPTHLPhetonN/A$30.96+6.2%N/AN/A$191.87M$450K0.0011News CoveragePositive NewsCVCapsoVisionN/A$4.35+8.8%$5.50+26.4%N/A$185.38MN/A0.0090News CoverageAnalyst RevisionINGNInogen4.1998 of 5 stars$6.79-0.1%$11.00+62.0%-31.8%$182.83M$335.70M-5.901,030Upcoming EarningsSGHTSight Sciences2.0728 of 5 stars$3.54+1.4%$3.93+11.1%-55.9%$180.42M$79.87M-3.61210TLSITriSalus Life Sciences2.1977 of 5 stars$4.55-0.2%$10.75+136.3%-27.9%$172.55M$29.43M-4.06106 Related Companies and Tools Related Companies Sanara MedTech Competitors Beauty Health Competitors Brainsway Competitors CVRx Competitors Monogram Orthopaedics Competitors Pheton Competitors CapsoVision Competitors Inogen Competitors Sight Sciences Competitors TriSalus Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
